Drugs / Oralgen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT00150514 | Jan 2002 → Dec 2006 | seasonal allergic rhinitis | Radboud University Medical Center | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 2/3 | NCT00824447 Comparator | Aug 2007 → Aug 2008 | allergic disease | Artu Biologicals | Completed | No outcome recorded |
| Phase 2/3 | NCT00567346 Comparator | Dec 2006 → Oct 2007 | allergic disease | Artu Biologicals | Completed | No outcome recorded |
| Phase 3 | NCT00812799 Comparator | Dec 2008 → Aug 2011 | allergic disease | Artu Biologicals | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oralgen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00812799 ↗ |
| Modality | Vaccine | “allergen vaccine (extract)” NCT00824447 ↗ |
| Route | Other | “allergen solution sublingually” NCT00824447 ↗ |